Eosinophil granule proteins are selective activators of human heart mast cells

International Archives of Allergy and Immunology

Volumn 113, Issue 1-3, 1997, Pages 200-202

  Patella, Vincenzo ^a   de Crescenzo, Gennaro ^a   Marinò, Gennaro ^a   Genovese, Arturo ^a   Adt, Monika ^b   Gleich, Gerald J ^c   Marone, Gianni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c MAYO CLINIC   (United States)

Author keywords

Eosinophils; Heart; Histamine; Mast cells; Tryptase

Indexed keywords

ANTIMYCIN A1; CALCIUM ION; CATION; CELL PROTEIN; DEOXYGLUCOSE; EOSINOPHIL CATIONIC PROTEIN; HISTAMINE; MAJOR BASIC PROTEIN; NEUROTOXIN; PEROXIDASE; TRYPTASE;

CELL ACTIVATION; CELL GRANULE; CONFERENCE PAPER; EOSINOPHIL; HEART DISEASE; HUMAN; HUMAN CELL; MAST CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

BLOOD PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHIL GRANULE PROTEINS; HEART; HUMANS; MAST CELLS; RIBONUCLEASES;

EID: 0030980467     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237546     Document Type: Article

References (26)

1. Löffler W: Endocarditis parietalis fibroblastica mit Bluteosinophilie, ein eigenartiges Krankheitsbild, Schweiz Med Wochcnschr 1936:66: 817-820.
2. Parrillo JE, Borer JS, Henry WL, Wolff SM, Fauci AS: The cardiovascular manifestations of the hypereosinophilic syndrome: Prospective study of 26 patients, with review of the literature, Am J Med 1979:67:572-582.
3. Desreumaux P, Janin A, Dubucqoui S, Copin M-C, Torpier G, Capron A, Capron M, Prin L: Synthesis of intcrlcukin-5 by activated eosinophils in patients with eosinophilic heart diseases, Blood 1993:82:1553-1560.
4. Dressier W: The postmyocardial infarction syndrome: A report of forty-four cases, Arch Intern Med 1963:21:698.
5. Tai PC, Ackerman SJ, Spry CJF, Olsen EGJ, Dunnettc S, Gleich GJ: Deposits of eosinophil granule proteins in cardiac tissues of patients w'ith eosinophilic endomyocardial disease, Lancet 1987:1:643-647.
6. de Mello DE, Liapis H, Jurcidini S, Nouri S, Kephart GM, Gleich GJ: Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis, N Engl,1 Med 1990: 323:1542-1545.
7. Tai P-C, Hayes DJ, Clark JB, Spry CJF: Toxic effects of human eosinophil secretion products on isolated rat heart cells in vitro, Biochem,1 1982;204:75-80.
8. Rohrbach MS, Wheatley CL, Slifman NR, Gleich GJ: Activation of platelets by eosinophil granule proteins, J Exp Med 1990:172:1271-1274.
9. Slungaard A, Vercellotti GM, Tran T, Gleich GJ, Key NS: Eosinophil cationic granule proteins impair thrombomodulin function, J Clin Invest 1993:91:1721-1730.
10. O'Donncl MC, Ackerman SJ, Gleich GJ, Thomas LL: Activation of basophils and mast cell histamine release by eosinophil granule major basic protein, J Exp Med 1991;157:1981-1991.
11. Zhcutlin LM, Ackerman SJ, Gleich GJ, Thomas LL: Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins, J Immunol 1984:133: 2180-2185.
12. Okayama Y, El-Lati SG, Leiferman KM, Church MK: Eosinophil granule proteins inhibit substance P-induccd histamine release from human skin mast cells, J Allergy Clin Immunol 1994:93:900-909.
13. Patella V, Marino I, Lamparter B, Arbustini E, Adt M, Marone G: I luman heart mast cells, Isolation, purification, ultrastructure, and immunologic characterization, J Immunol 1995:154: 2855-2865.
14. Patella V, de Crescenzo G, Ciccarelli A, Marino I, Adt M, Marone G: Human heart mast cells: A definitive case of mast cell heterogeneity, Int Arch Allergy Immunol 1995:106:386-393.
15. Slifman NR, Locgering DA, McKean DJ, Gleich GJ: Ribonucleasc activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein, J Immunol 1986: 137:2913-2917.
16. Patella V, Casolaro V, Björck L, Marone G: Protein L: A bacterial lg-binding protein that activates human basophils and mast cells, J Immunol 1990:145:3054-3061.
17. Patella V, Bouvet J-P, MaroneG: Protein Fv produced during viral hepatitis is a novel activator of human basophils and mast cells, J Immunol 1993:151:5685-5698.
18. Stcllato C, de Paulis A, Cirillo R, Mastronardi P, Mazzarella B, Marone G: Heterogeneity of human mast cells and basophils in response to muscle relaxants, Anesthesiology 1991;74: 1078-1086.
19. Snedccor GW, Cochran WG: Statistical Methods, Ames, Iowa State University Press, 1980.
20. Gleich GJ, Frigas E, Loegering DA, Wassom DL, Steinmuller D: Cytotoxic properties of the eosinophil major basic protein, J Immunol 1979:123:2925-2927.
21. Vigorito C, Poto S, Picotti GB, Triggiani M, Marone G: Effect of activation of the H, receptor on coronary hemodynamics in man, Circulation 1986:73:1175-1182.
22. Marone G, Giordano A, Cirillo R, Triggiani M, Vigorito C: Cardiovascular and Metabolic Effects of peptide Icukotricncs in man, Am NY Acad Sei 1988:524:321-333.
23. Marone G, de Crescenzo G, Adt M, Patella V, Arbustini E, Genovese A: Immunological characterization and functional importance of human heart mast cells, Immunopharmacology 1995:31:1-18.
24. Asscm ESK: Release of eosinophil cationic protein (ECP) in anaphylactoid anaesthetic reactions in vivo and in vitro, Agents Actions 1994;41 (Spec Conf Issue)
25. Niggemann B, Beyer K, Wahn U: The role of eosinophils and eosinophil cationic protein in monitoring oral challenge tests in children w'ith food-sensitive atopic dermatitis, J Allergy Clin Immunol 1994;94:963-971.
26. Smith PL, Kagey-Sobotka A, Bleecker FR, Traystman R, Kaplan AP, Gralnick H, Valentine MD, Permutt S, Lichtenstein LM: Physiologic manifestations of human anaphylaxis, J Clin Invest 1980;66:1072-1080